Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design
Casect Launches AI-Enhanced Case Log Platform for Surgeons
CorVel Announces Effectiveness of Three-For-One Forward Stock Split
Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
Best Testosterone Supplement For Men Over 40 and 50: Testo Prime for Muscle Growth & Libido 2025
In KESTREL and KITE, Beovu (brolucizumab) 6 mg met the primary endpoints of non-inferiority in change in best corrected visual...
CHICAGO, April 30, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform...
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., April 30, 2021 (GLOBE NEWSWIRE)...
PARIS, FRANCE / ACCESSWIRE / April 30, 2021 / Abivax SA (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company developing...
DALLAS, TX / ACCESSWIRE / April 30, 2021 / Millennium Family Practice, in Columbia, Maryland, provides quality medical care for people...
ImmunopheresisTM is shown to be well-tolerated in treating cancer patients who failed multiple lines of standard therapies SAN DIEGO--(BUSINESS WIRE)--#biotech--Immunicom,...
WATERLOO, ON / ACCESSWIRE / April 30, 2021 / Cloud DX (TSXV:CDX) (The Company) a leading Canadian provider of virtual...
A Presentation of Positive Preliminary Efficacy Results from the FOCUS Phase III trial Company Q&A Webinar Scheduled for Monday, June 7,...
PRAX-562 Phase 2 clinical trial for treatment of DEEs expected to initiate in first half of 2022CAMBRIDGE, Mass., April 30,...
REDWOOD CITY, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or “the Company”, Nasdaq: CHRS), today announced...
A single-day dose of oral ibrexafungerp demonstrates positive clinical outcomes in difficult-to-treat vulvovaginal candidiasis (VVC) patient populations: those with non-albicans...
The partnership builds on Sientra’s safety profile by empowering surgeons with Butterfly Network’s cutting-edge point-of-care ultrasound technology to screen and...
SAN FRANCISCO and SAN DIEGO, April 30, 2021 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company...
Conference Call and Webcast Scheduled for May 6, 2021, 4:30 p.m. Eastern TimePRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) --...
SAN JOSE, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”)...
NEW YORK, April 30, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global biopharmaceutical company...
Press release FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Eric Nys, general manager, eric.nys@financiere-tubize.be Approval...
Study to be Conducted at The University of Texas MD Anderson Cancer CenterLONDON and REDWOOD CITY, Calif. and HOUSTON, Texas,...
TORONTO, April 30, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced that it...
FORT LAUDERDALE, Fla., April 30, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"),...
